Literature DB >> 23852839

The efficacy of clarithromycin in patients with severe nasal polyposis.

Payman Dabirmoghaddam1, Jalal Mehdizadeh Seraj, Shahin Bastaninejad, Ali Meighani, Zahra Mokhtari.   

Abstract

Although several treatments have been suggested for nasal polyposis, from medical to surgical, there is no standard guideline for the management of this disease. During recent years increasing attention has been directed toward the effects of macrolide antibiotics on chronic sinusitis and nasal polyposis. In this study,  the efficacy of clarithromycin on severe nasal polyposis were examined. In a Prospective, before - after study, forty patients with severe nasal polyposis received clarithromycin 500 mg twice a day for 8 weeks. At the beginning and end of treatment, the severity of patients' symptoms (using subjective analogue scale), computed tomography (CT) scan and endoscopic findings were recorded. After treatment, the severity of nasal obstruction, smelling problems, Post Nasal Discharge and rhinorrhea decreased significantly (P<0.05). Furthermore, the degree of sinus opacification in CT scan and endoscopic findings showed significant improvement. Most patients completed their treatment course without significant side effects. Although a course of clarithromycin improved nasal symptoms, polyp size and CT findings, further studies with more patients are required to recommend this drug as a general treatment in nasal polyposis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852839

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  3 in total

Review 1.  The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP).

Authors:  Gretchen M Oakley; Richard J Harvey; Valerie J Lund
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

Review 2.  Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.

Authors:  Anders Cervin; Ben Wallwork
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

3.  Evaluation of the improvement of quality of life with Azithromycin in the treatment of eosinophilic nasal polyposis.

Authors:  Isamara Simas de Oliveira; Paulo Fernando Tormin Borges Crosara; Geovanni Dantas Cassali; Diego Carlos dos Reis; Camilo Brandão de Resende; Flavio Barbosa Nunes; Roberto Eustáquio Santos Guimarães
Journal:  Braz J Otorhinolaryngol       Date:  2015-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.